mci 9038 has been researched along with Brain Edema in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (84.62) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JL; Chen, W; Fan, RM; Han, C; Jiao, S; Li, G; Wang, CM; Xia, XP; Yao, ST; Zeng, YC | 1 |
Ayer, R; Chen, W; Jadhav, V; Sugawara, T; Suzuki, H; Zhang, JH | 1 |
Qu, F; Zhang, CD; Zhou, ZH | 1 |
Hoff, JT; Hua, Y; Keep, RF; Kitaoka, T; Xi, G | 1 |
Amemiya, S; Kamiya, T; Katayama, Y; Kato, K; Nito, C; Terashi, A; Ueda, M | 1 |
Hoff, JT; Hua, Y; Keep, RF; Kitaoka, T; Nagao, S; Xi, G | 1 |
Hoff, JT; Hua, Y; Keep, RF; Schallert, T; Xi, G | 1 |
Shinohara, Y | 1 |
Fujisawa, H; Koizumi, H; Nagatsuna, T; Nomura, S; Suehiro, E; Suzuki, M | 1 |
Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, LL; Xi, GH | 1 |
Hosomi, N; Kohno, M; Mizushige, K; Ohyama, H; Takahashi, T | 1 |
Jin, YJ; Mima, T; Park, KC; Raicu, V; Shimizu, K | 1 |
Hamada, R; Matsuoka, H | 1 |
2 review(s) available for mci 9038 and Brain Edema
Article | Year |
---|---|
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?
Topics: Antithrombins; Arginine; Brain; Brain Edema; Cerebral Hemorrhage; Humans; Neurons; Pilot Projects; Pipecolic Acids; Sulfonamides; Survival Rate; Thrombin; Treatment Outcome | 2002 |
11 other study(ies) available for mci 9038 and Brain Edema
Article | Year |
---|---|
Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
Topics: Animals; Apoptosis; Arginine; Brain Edema; Cerebral Hemorrhage; Complement C5a; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Peptides, Cyclic; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptor, Anaphylatoxin C5a; RNA, Messenger; Stroke; Sulfonamides; Tubulin | 2014 |
Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats.
Topics: Animals; Anticoagulants; Arginine; Blood-Brain Barrier; Brain Edema; Cell Death; Disease Models, Animal; Male; Motor Activity; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Recovery of Function; Subarachnoid Hemorrhage; Sulfonamides; Thrombin | 2009 |
Systemic administration of argatroban inhibits protease-activated receptor-1 expression in perihematomal tissue in rats with intracerebral hemorrhage.
Topics: Animals; Arginine; Blotting, Western; Body Water; Brain Chemistry; Brain Edema; Cerebral Hemorrhage; Female; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, PAR-1; Stereotaxic Techniques; Sulfonamides | 2011 |
Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage.
Topics: Animals; Antithrombins; Arginine; Brain; Brain Chemistry; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemoglobins; Infusions, Parenteral; Male; Microinjections; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Sulfonamides; Time Factors; Treatment Outcome; Water | 2002 |
Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats.
Topics: Animals; Antithrombins; Arginine; Brain Edema; Cerebral Cortex; Cerebral Infarction; Hypothermia, Induced; Ischemic Attack, Transient; Male; Neuroprotective Agents; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides | 2003 |
Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat.
Topics: Animals; Antithrombins; Arginine; Brain; Brain Edema; Cerebral Hemorrhage; Collagenases; Drug Administration Schedule; Hematoma; Injections; Injections, Intraperitoneal; Male; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides | 2003 |
A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model.
Topics: Animals; Antithrombins; Arginine; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Glioma; Immunohistochemistry; Nervous System Diseases; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Thrombin | 2003 |
Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment.
Topics: Animals; Anticoagulants; Arginine; Astrocytes; Brain Edema; Cerebral Hemorrhage; Hematoma; Male; Neutrophils; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides | 2005 |
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Topics: Animals; Anticoagulants; Antineoplastic Agents; Arginine; Brain; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Injections, Intraventricular; Male; Mental Disorders; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Treatment Outcome | 2005 |
Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia.
Topics: Animals; Antithrombins; Arginine; Aspirin; Blood Pressure; Brain Edema; Cerebrovascular Circulation; Fibrinolytic Agents; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Methacrylates; Microcirculation; Nerve Degeneration; Neurons; Pipecolic Acids; Sulfonamides; Survival Rate; Thrombin | 2001 |
Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.
Topics: Animals; Anticoagulants; Antipyrine; Arginine; Body Water; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Edaravone; Endothelium, Vascular; Free Radical Scavengers; Free Radicals; Gerbillinae; Male; Nerve Degeneration; Neuroprotective Agents; Pipecolic Acids; Prosencephalon; Reperfusion Injury; Sulfonamides | 2002 |